Results
69
High return on equity, past performance and sound balance sheet.
69 companies
Procter & Gamble Health
Market Cap: ₹96.8b
Engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally.
500126
₹5,831.90
7D
-0.7%
1Y
11.4%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹534.4b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹3,154.75
7D
0.3%
1Y
16.4%
Abbott India
Market Cap: ₹717.6b
Operates as a pharmaceutical company in India.
500488
₹33,771.20
7D
-1.1%
1Y
17.9%
Orion Oyj
Market Cap: €9.9b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€70.55
7D
1.6%
1Y
71.1%
Johnson & Johnson
Market Cap: US$408.4b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$168.30
7D
2.8%
1Y
4.8%
Medpace Holdings
Market Cap: US$12.8b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$447.49
7D
43.5%
1Y
17.3%
Xiamen Amoytop Biotech
Market Cap: CN¥30.9b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥75.99
7D
0.7%
1Y
52.7%
Torrent Pharmaceuticals
Market Cap: ₹1.2t
Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹3,602.50
7D
2.3%
1Y
12.9%
ChemoMetec
Market Cap: DKK 9.0b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 515.00
7D
-1.9%
1Y
33.1%
Blue Jet Healthcare
Market Cap: ₹136.9b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹789.25
7D
-21.9%
1Y
76.8%
Exelixis
Market Cap: US$12.2b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$45.60
7D
2.5%
1Y
95.0%
Waters
Market Cap: US$17.8b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$302.95
7D
5.4%
1Y
-4.7%
Jamjoom Pharmaceuticals Factory
Market Cap: ر.س12.4b
Manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally.
4015
ر.س176.70
7D
0.2%
1Y
17.0%
Henan Lingrui Pharmaceutical
Market Cap: CN¥13.0b
Produces and sells medicines in China.
600285
CN¥23.12
7D
1.3%
1Y
9.3%
Concord Biotech
Market Cap: ₹196.8b
A biopharma company, engages in the research and development, manufacturing, marketing, and sale of pharmaceutical products in India and internationally.
CONCORDBIO
₹1,880.80
7D
-0.7%
1Y
10.5%
Laboratorios Farmaceuticos Rovi
Market Cap: €2.8b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€55.55
7D
5.2%
1Y
-37.3%
EZZ Life Science Holdings
Market Cap: AU$101.0m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
EZZ
AU$2.14
7D
-7.4%
1Y
6.5%
Ajanta Pharma
Market Cap: ₹347.7b
A pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages.
AJANTPHARM
₹2,784.30
7D
0.4%
1Y
15.9%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥43.3b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.
688578
CN¥96.16
7D
-3.0%
1Y
87.7%
Middle East Pharmaceutical Industries
Market Cap: ر.س2.3b
Engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally.
4016
ر.س116.30
7D
-2.7%
1Y
-9.0%
Imeik Technology DevelopmentLtd
Market Cap: CN¥57.7b
Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.
300896
CN¥191.57
7D
7.8%
1Y
15.4%
Consun Pharmaceutical Group
Market Cap: HK$10.7b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$12.88
7D
4.0%
1Y
126.0%
DHG Pharmaceutical
Market Cap: ₫13.5t
Engages in the manufacture and sale of pharmaceutical products in Vietnam.
DHG
₫103,000.00
7D
1.7%
1Y
-8.0%
Shandong Wit Dyne HealthLtd
Market Cap: CN¥7.7b
Engages in the pharmaceutical business in China.
000915
CN¥32.95
7D
-0.3%
1Y
16.8%
PeptiDream
Market Cap: JP¥221.1b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥1,712.00
7D
5.7%
1Y
-35.4%
Catalyst Pharmaceuticals
Market Cap: US$2.6b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$20.97
7D
-0.3%
1Y
19.2%
WuXi AppTec
Market Cap: CN¥253.3b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥88.88
7D
7.6%
1Y
124.8%
Genmab
Market Cap: DKK 91.7b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,490.50
7D
5.0%
1Y
-23.3%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥24.3b
Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.
600329
CN¥36.11
7D
-0.9%
1Y
10.4%
NATCO Pharma
Market Cap: ₹173.3b
A pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.
NATCOPHARM
₹967.65
7D
-6.5%
1Y
-27.5%
OSE Immunotherapeutics
Market Cap: €143.6m
A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.
OSE
€6.28
7D
17.9%
1Y
-17.5%
Sichuan Biokin PharmaceuticalLtd
Market Cap: CN¥122.1b
Engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally.
688506
CN¥304.58
7D
-5.1%
1Y
88.1%
Memphis Pharmaceuticals & Chemical Industries
Market Cap: ج.م2.1b
A drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally.
MPCI
ج.م93.83
7D
10.2%
1Y
5.5%
RPG Life Sciences
Market Cap: ₹41.2b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,491.80
7D
-0.6%
1Y
29.8%
Central Pharmaceutical No3
Market Cap: ₫1.1t
Engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally.
DP3
₫53,000.00
7D
0%
1Y
-17.4%
AprilBioLtd
Market Cap: ₩506.9b
AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.
A397030
₩22,500.00
7D
-2.2%
1Y
21.0%